The 58th Annual Scientific Meeting of the Japanese Society for Pediatric Endocrinology

＊indicates required fields, so please make sure to fill them out.
After applying, you will receive a registration completion email to the email address you provided. Please note that it may be sorted into your "spam" box.
If you have any questions or concerns, please do not hesitate to contact us at the following address.

c/o CREDO CORPORATION
10F, Shibadaimon Center Building,
1-10-11, Shibadaimon, Minato-ku,
Tokyo 105-0012
TEL：81-3-6435-9885
E-mail：jspe58@credoinc.jp

Applicants Category, Session Category, Abstract Category

Applicants Category *

1. Physician, Researcher

2. Healthcare professionals(excluding Physician, Researcher)

3. Student(excluding graduate students), Clinical resident (until the second year))

*"3" is for students(excluding graduate students) and clinical residents (until the second year) at the time of presentation.

Session Category *

1. Basic Scientific Research

2. Clinical Scientific Research

3. Clinical Case Report

4. Clinical trial, Post-marketing surveillance

Abstract Category First choice *

Abstract Category Second choice (Optional)

Was the abstract published before August 31st, 2024? "In press" regarded as published.*

1. The abstract was not published before August 31st, 2024.

2. The abstract was published before August 31st, 2024.(not eligible for the Best Presentation Prize and the Young Presenter Award.)

First author

The first author is a member of the Japanese Society for Pediatric Endocrinology (JSPE), (annual membership fee paid for 2024) or is in the process of applying for membership at the time of application.*

The first author is from overseas.*

The first author is students (excluding graduate students) ,or post-graduate clinical residents (until the second year).*

Name *

Birth date

*Required for only who was born after April 2, 1985

Password *

Create and type your View/Update Password.
The Password is case sensitive and must be between 4 and 12 characters long.
This password is necessary for you to view or modify your abstract.

Confirm password *

Institution *

*Please abbreviate it like "Dept. of Pediatr.,○○ Univ. Sch . of Med. /○○ Hosp.".

Zip code

Address *

City *

Pref/State *

Country *

Phone number

FAX

E-MAIL address *

Confirm E-MAIL address *

Presenter Contact

Please select the presenter. *

First author

Co-author

Other than the first author and co-authors.

*If the first author is the presenter, input of information such as name below is not necessary.

Name of the Presenter *

Institution of the Presenter *

*Please abbreviate it like "Dept. of Pediatr.,○○ Univ. Sch . of Med. /○○ Hosp.".

Zip code of the Presenter

Address of the Presenter *

City of the Presenter *

Pref/State of the Presenter *

Country of the Presenter *

Phone number of the Presenter

E-MAIL address of the Presenter *

Confirm E-MAIL address *

Institution

If the co-authors are affiliated with several institutions, enter all the institutions below and check the box of Institution in the co-author section.
*Please abbreviate it like "Dept. of Pediatr.,○○ Univ. Sch . of Med. /○○ Hosp.".

Institution 1

Institution 2

Institution 3

Institution 4

Institution 5

Institution 6

Institution 7

Institution 8

Institution 9

Institution 10

Institution 11

Institution 12

Institution 13

Institution 14

Institution 15

Add more fields for Institutions

Co-author

Co-author1 Name

Co-author2 Name

Co-author3 Name

Co-author4 Name

Co-author5 Name

Add more fields for co-authors

Title, diagram and abstract

Abstract title *

(Less than 30 words)

Check here if your abstract includes a diagram *

1. No

2. Yes

Abstract(Less than 400 words) * Abstract(Less than 268 words) *

As a general rule, the body of the abstract should be written with the following titles.

■ Basic Scientific Research, Clinical Scientific Research, Clinical trial and Post-marketing surveillance
[Introduction] [Purpose] [Methods] (or [Subject & Methods])[Results] [Discussion] [Conclusion]
■ Clinical Case Report
[Introduction] [Case] [Discussion] [Conclusion]

Diagram file *

*Uploadable file format: 「jpg」、「jpeg」、「gif」、「zip」

Use of Generative AI in Abstract Creation and Presentations at Annual Scientific Meeting of the JSPE

Please select whether generative AI was used.*

Used

Not used

Please confirm that the presenter takes final responsibility for the presentation content, including parts generated using generative AI
(including accuracy, personal information protection, and copyright issues)*

I have confirmed and will proceed with the abstract submission.

Ethical Considerations for Presentations at the Annual Scientific Meeting of the Japanese Society of Pediatric Endocrinology Please refer to the PDF and check the following items regarding ethical considerations. Ethical Considerations for Presentations at the Annual Scientific Meeting of the Japanese Society of Pediatric Endocrinology[PDF]
This presentation corresponds to a subject that requires the approval by an ethical review board. Approved by an ethical review board. Obtain ethical review approval at least one month prior to presentation. This presentation does not correspond to a subject that requires the approval by an ethical review board. Case report Others (research such as animal experiments that do not involve human subjects, research that uses only widely used cell lines, research that only analyzes papers and published databases, etc.)

Ethical Considerations for Presentations at the Annual Scientific Meeting of the Japanese Society of Pediatric Endocrinology

Please refer to the PDF and check the following items regarding ethical considerations.
Ethical Considerations for Presentations at the Annual Scientific Meeting of the Japanese Society of Pediatric Endocrinology[PDF]

This presentation corresponds to a subject that requires the approval by an ethical review board.

: Approved by an ethical review board.

: Obtain ethical review approval at least one month prior to presentation.

This presentation does not correspond to a subject that requires the approval by an ethical review board.

: Case report

: Others (research such as animal experiments that do not involve human subjects, research that uses only widely used cell lines, research that only analyzes papers and published databases, etc.)

Regarding the declaration of conflict of interest by the presenter (first author and co-authors). Relatives" for questions 1-3 refer to the spouse, first-degree relatives, and those who share the same household as the applicant. The amounts in questions 6-8 represent the total sum of research fees, grants, donations, etc. from companies or organizations that have a COI relationship that should be disclosed, which the applicant can essentially decide the purpose for. It is also necessary to declare information about the first author and co-authors. Please check either "yes" or "no" for questions 1-1 to 9-2, and if you have checked "yes," please provide the necessary information. This declaration form is archived for 2 years after the presentation.
Q1-1　(regarding the first author) Employment/Leadership position/ Advisory role (1,000,000 yen* or more, per year)	Yes No
Q1-2　(regarding relatives) Employment/Leadership position/ Advisory role (1,000,000 yen* or more, per year)	Yes No
Q1-3　(regarding co-authors) Employment/Leadership position/ Advisory role (1,000,000 yen* or more, per year)	Yes No
Q2-1　(regarding the first author) Stock ownership or options (Profit of 1,000,000 yen per year or more/ownership of 5% or more of total shares)	Yes No
Q2-2　(regarding relatives) Stock ownership or options (Profit of 1,000,000 yen per year or more/ownership of 5% or more of total shares)	Yes No
Q2-3　(regarding co-authors) Stock ownership or options (Profit of 1,000,000 yen per year or more/ownership of 5% or more of total shares)	Yes No
Q3-1　(regarding the first author) Patent royalties/licensing fees (1,000,000 yen or more, per year)	Yes No
Q3-2　(regarding relatives) Patent royalties/licensing fees (1,000,000 yen or more, per year)	Yes No
Q3-3　(regarding co-authors) Patent royalties/licensing fees (1,000,000 yen or more, per year)	Yes No
Q4-1　(regarding the first author) Honoraria (e.g. lecture fees) (500,000 yen or more, per year)	Yes No
Q4-2　(regarding co-authors) Honoraria (e.g. lecture fees) (500,000 yen or more, per year)	Yes No
Q5-1　(regarding the first author) Fees for promotional materials (e.g. manuscript fee) (500,000 yen or more, per year)	Yes No
Q5-2　(regarding co-authors) Fees for promotional materials (e.g. manuscript fee) (500,000 yen or more, per year)	Yes No
Q6-1　(regarding the first author) Research funding (e.g. clinical trial, contract and collaborative research) (1,000,000 yen or more, per year)	Yes No
Q6-2　(regarding co-authors) Research funding (e.g. clinical trial, contract and collaborative research) (1,000,000 yen or more, per year)	Yes No
Q7-1　(regarding the first author) Scholarship donation (1,000,000 yen or more, per year)	Yes No
Q7-2　(regarding co-authors) Scholarship donation (1,000,000 yen or more, per year)	Yes No
Q8-1　(regarding the first author) Donated fund laboratory (1,000,000 yen or more, per year)	Yes No
Q8-2　(regarding co-authors) Donated fund laboratory (1,000,000 yen or more, per year)	Yes No
Q9-1　(regarding the first author) Others (e.g. trips, travel, or gifts, which are not related to research) (50,000 yen or more, per year)	Yes No
Q9-2　(regarding co-authors) Others (e.g. trips, travel, or gifts, which are not related to research) (50,000 yen or more, per year)	Yes No
Did you have any conflicts of interest (COI) that should be disclosed in any of the questions from 1-1 to 9-2? (Automatically selected)	Yes No

The 58th Annual Scientific Meeting of the Japanese Society for Pediatric Endocrinology - New -

As a general rule, the body of the abstract should be written with the following titles.

Ethical Considerations for Presentations at the Annual Scientific Meeting of the Japanese Society of Pediatric Endocrinology

Regarding the declaration of conflict of interest by the presenter (first author and co-authors).

The 58th Annual Scientific Meeting of the Japanese Society for Pediatric Endocrinology
- New -